The Department for Experimental Molecular Imaging (ExMI) at the University Hospital Aachen and the Helmholtz Institute for Biomedical Engineering at RWTH Aachen University is headed by Univ.-Prof. Dr. med. Fabian Kiessling.

ExMI focuses on the development of novel contrast agents, imaging techniques and therapeutic approaches to characterize and treat cancer, cardiovascular and inflammatory disorders.

ExMI currently consists of five research groups, working on

• biological mechanisms of angiogenesis and tumor progression,
• the synthesis of novel molecular imaging probes,
• nanomedicines and theranostics,
• physics in molecular imaging systems, and
• applications in medical informatics.

News

• Volkmar Schulz has been appointed Professor in the Medical Faculty of RWTH Aachen University
• Yannick will be presented with the JNM Editors’ Choice Award 2012 at the upcoming SNMMI Annual Meeting
• Wael’s paper “Polymeric nanoparticles as OCT contrast agents” accepted at the Journal of Nanoparticle Research